Completed NA INTERVENTIONAL 2-arm NCT02312531

Prevention for Mother-to-infant Transmission of HBV

HBIG for Prevention of Mother-to-infant HBV Transmission

Sponsor: Xi'an Jiaotong University

Conditions HBV

Interventions Hepatitis B immunoglobulin

Updated 7 times since 2017 Last updated: Dec 8, 2014 Started: May 31, 2012 Primary completion: May 31, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02312531, this NA trial focuses on HBV and remains completed. Sponsored by Xi'an Jiaotong University, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Feb 2025 — Present [monthly]

Completed NA
Sep 2024 — Feb 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Sep 2020 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Sep 2020 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xi'an Jiaotong University

Data source: Xi'an Jiaotong University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.